Presentation of the cluster

Dr Michael Courtney is Chairman and CEO at Imaxio SA (previously Aptanomics SA), a privately-held drug discovery and development company based in Lyon (France).

Previously, he was Chief Operating Officer at Noxxon Pharma AG (Berlin, Germany).

From 1991 to 2001 Dr Courtney was Chief Scientific Officer at Transgene SA (Strasbourg, France) and from 1989-91 he was Director of Research at Delta Biotechnology Ltd (Nottingham, UK). Dr Courtney received a BSc (hons) from the University of Glasgow (UK) and a PhD from the University of London (UK).

 

Dr Courtney has gained broad international experience in research, product development, corporate alliances, private placements and, with Transgene, a $100M IPO on the NASDAQ and Nouveau Marché in France. He has authored over 70 publications in international peer-reviewed scientific and medical journals.